- Home
- NEO vs ALHC Comparison
NEO vs ALHC Comparison
Compare NEO & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- ALHC
- Stock Information
- Founded
- NEO 2001
- ALHC 2013
- Country
- NEO United States
- ALHC United States
- Employees
- NEO N/A
- ALHC N/A
- Industry
- NEO Precision Instruments
- ALHC Medical Specialities
- Sector
- NEO Health Care
- ALHC Health Care
- Exchange
- NEO Nasdaq
- ALHC Nasdaq
- Market Cap
- NEO 2.3B
- ALHC 2.3B
- IPO Year
- NEO 1999
- ALHC 2021
- Fundamental
- Price
- NEO $16.53
- ALHC $10.61
- Analyst Decision
- NEO Strong Buy
- ALHC Buy
- Analyst Count
- NEO 10
- ALHC 9
- Target Price
- NEO $20.30
- ALHC $11.88
- AVG Volume (30 Days)
- NEO 756.1K
- ALHC 1.7M
- Earning Date
- NEO 02-18-2025
- ALHC 10-29-2024
- Dividend Yield
- NEO N/A
- ALHC N/A
- EPS Growth
- NEO N/A
- ALHC N/A
- EPS
- NEO N/A
- ALHC N/A
- Revenue
- NEO $644,118,000.00
- ALHC $2,467,707,000.00
- Revenue This Year
- NEO $12.98
- ALHC N/A
- Revenue Next Year
- NEO $9.83
- ALHC $29.24
- P/E Ratio
- NEO N/A
- ALHC N/A
- Revenue Growth
- NEO 12.06
- ALHC 43.47
- 52 Week Low
- NEO $12.77
- ALHC $4.46
- 52 Week High
- NEO $21.22
- ALHC $14.25
- Technical
- Relative Strength Index (RSI)
- NEO 44.50
- ALHC 38.39
- Support Level
- NEO $17.24
- ALHC $10.93
- Resistance Level
- NEO $18.20
- ALHC $11.58
- Average True Range (ATR)
- NEO 0.70
- ALHC 0.58
- MACD
- NEO -0.28
- ALHC -0.17
- Stochastic Oscillator
- NEO 6.41
- ALHC 13.65
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.